An Electronic Case Report Form (eCRF) is the electronic version of a clinical trial’s case report form. Using the eCRF, investigational sites document structured study data per subject or patient, usually within an electronic data capture system. The aim is standardized, traceable, quality-assured data collection as the basis for analyses, the marketing authorization dossier, and subsequent inspections.
Purpose and content of an eCRF
The eCRF reflects the data elements defined in the protocol that are required to answer the study question. Typical content includes screening information, randomization and treatment data, visit parameters, laboratory values, concomitant medication, adverse events, and endpoint data. A well-designed eCRF follows the principle “as little as possible, as much as necessary”: unnecessary fields increase workload and the risk of errors, while missing fields can jeopardize later analyses and regulatory evidence.
Design principles: From data definition to the data entry screen
Development usually starts with the data management plan, the CRF completion guideline, and a formal data specification (e.g., an annotated CRF as a bridge to SDTM/ADaM). Clear definitions of variables, units, time points, and permitted ranges are key. In eCRF design, these specifications are translated into forms, including required fields, dynamic logic (e.g., conditional questions), visit windows, and consistent user guidance. In practice, an iterative process is important: Medical, Biostatistics, Data Management, Monitoring, and the sponsor should review early to minimize later change requests.
A proven approach is to define already during CRF design which data are “critical to quality” and therefore require stricter controls. This often includes primary endpoints, key criteria for the analysis population, essential safety data, and data points that are typically the focus of regulatory questions. This prioritization helps keep the eCRF lean while still capturing the decisive information robustly.
In international programs, language- and country-specific requirements must also be considered (e.g., different laboratory reference ranges or documentation practices). Clear role allocation (who is allowed to correct what?), defined timelines for query responses, and an established change-control process are essential to ensure that late adjustments do not lead to data discontinuities.
Edit checks, queries, and data quality
eCRFs are closely linked to automated and manual plausibility checks. Edit checks verify, for example, value ranges, date consistency, missing required fields, or logical contradictions. When a check triggers, a query is generated that the site must clarify and answer. The balance is crucial: overly strict checks lead to many irrelevant queries and delays, while overly weak checks allow inconsistencies to persist until shortly before database lock. In addition, central data reviews (listings, outlier checks) and reconciliations with external data sources (e.g., laboratory data, ePRO) are often performed.
In practice, it is worthwhile to standardize query rules and correction processes early: Which roles may open queries, who closes them, and when is a data correction considered “locked”? Without clear rules, duplicate or contradictory follow-up questions arise between Monitoring and Data Management. Consistency across visits is equally important: recurring measurements (e.g., vital signs) should use identical field names, units, and permitted values so that analyses and plausibility checks work reliably.
Another common quality lever is consistent management of missing data. Instead of only setting required fields, it should be defined how “not collected”, “not applicable”, or “unknown” is coded. These seemingly small details later determine whether data can be cleanly mapped to standards (e.g., CDISC) and whether statistical analyses are possible without extensive data cleaning.
Regulatory requirements: audit trail, GCP, and inspection readiness
Because eCRFs can form the basis for marketing authorization and scientific publication, their use must be GCP-compliant. Relevant requirements include, in particular, traceability of changes (audit trail), unique user identities, role-based access rights, data backup, system validation, and documented SOPs. For EU studies, ICH-GCP principles (E6(R2)/E6(R3)) and the EU Clinical Trials Regulation (EU) No. 536/2014 are relevant in practice. In international programs, alignment with 21 CFR Part 11 may also be advisable to handle electronic records and signatures consistently.
Distinction: eCRF vs. EDC vs. ePRO
The eCRF is the specific form or data entry interface. The EDC is the system that hosts eCRFs and provides functions such as role management, audit trail, query management, and data export. ePRO/eCOA systems capture patient-reported data (e.g., symptoms, quality of life) often separately; these data are typically transferred into the EDC via interfaces or merged in the statistical database. For the sponsor and CRO, it is important to define processes for data reconciliation and responsibilities within quality management.
FAQ: Who creates the eCRF in a clinical trial?
In practice, the eCRF is usually created by Data Management (sponsor or CRO) in close coordination with Medical, Biostatistics, and Monitoring. The sponsor retains overall responsibility but can contractually delegate tasks to a CRO. Vendors often provide the EDC system and support the build.
FAQ: When should the eCRF be final?
Ideally, the eCRF is finally validated before first patient first visit, including user acceptance testing and training. Late changes increase the risk of data inconsistencies, require change control, and may necessitate additional training as well as data migrations.
FAQ: Which documents support day-to-day eCRF use?
Key documents include CRF completion guidelines, the data management plan, the system’s validation documentation, training records, and SOPs for query handling, data corrections, and change control. These documents are regularly requested during audits and inspections.
Regulatory references (selection): ICH E6(R3) Good Clinical Practice, EU Clinical Trials Regulation (EU) No. 536/2014, General Data Protection Regulation (EU) 2016/679; for US relevance: 21 CFR Part 11.